Literature DB >> 26506830

Can C-reactive protein and white blood cell count alone rule out an urgent condition in acute abdominal pain?

Ciro Paolillo1, Ilenia Spallino2.   

Abstract

Up to 10% of all patients at the Emergency Department present for acute abdominal pain. The C-reactive protein (CRP) and white blood cell (WBC) are routinely determined as part of the workup of patients with abdominal pain. Three large prospective cohort studies comprising a total of 2961 adult patients with acute abdominal pain were selected. CRP levels and WBC counts were compared between patients with urgent and nonurgent final diagnoses. These studies conclude that the laboratory values individually are weak discriminators and cannot be used as a triage instrument in the selection of patients with acute abdominal pain requiring additional diagnostic tests.

Entities:  

Keywords:  Abdominal pain; Acute abdomen; C-reactive protein (CRP); White blood cell (WBC)

Mesh:

Substances:

Year:  2015        PMID: 26506830     DOI: 10.1007/s11739-015-1333-2

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN: 1828-0447            Impact factor:   3.397


  3 in total

Review 1.  Guideline for the diagnostic pathway in patients with acute abdominal pain.

Authors:  Sarah L Gans; Margreet A Pols; Jaap Stoker; Marja A Boermeester
Journal:  Dig Surg       Date:  2015-01-28       Impact factor: 2.588

2.  Imaging strategies for detection of urgent conditions in patients with acute abdominal pain: diagnostic accuracy study.

Authors:  Wytze Laméris; Adrienne van Randen; H Wouter van Es; Johannes P M van Heesewijk; Bert van Ramshorst; Wim H Bouma; Wim ten Hove; Maarten S van Leeuwen; Esteban M van Keulen; Marcel G W Dijkgraaf; Patrick M M Bossuyt; Marja A Boermeester; Jaap Stoker
Journal:  BMJ       Date:  2009-06-26

3.  C-reactive protein and white blood cell count as triage test between urgent and nonurgent conditions in 2961 patients with acute abdominal pain.

Authors:  Sarah L Gans; Jasper J Atema; Jaap Stoker; Boudewijn R Toorenvliet; Helena Laurell; Marja A Boermeester
Journal:  Medicine (Baltimore)       Date:  2015-03       Impact factor: 1.889

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.